Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Sponsored By: Representative Green, Al (TX)
Introduced
Summary
Adds 'renal medullary carcinoma' to Medicaid education for people with sickle cell disease, expanding what risk information states can provide. It would let states claim Medicaid payment for those education services. *It would allow states to receive federal Medicaid matching payments covering 50% of those education costs.*
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Medicaid education on renal medullary carcinoma
If enacted, Medicaid could include renal medullary carcinoma in education and informational incentives for people with sickle cell disease. This would apply to items and services given on or after the date of enactment. It would not create a new program or new funding.
Sponsors & CoSponsors
Sponsor
Green, Al (TX)
TX • D
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in